IDO-IN-18
IDO-IN-18 (Compound 00815) is an IDO inhibitor. IDO-IN-18 can be used for research of immunosuppression associated infectious or cancer diseases[1].
Product Specifications
CAS Number
[314027-92-4]
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Indoleamine 2,3-Dioxygenase (IDO)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ido-in-18.html
Purity
96.34
Solubility
DMSO : 16.67 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(O)CSC1=NN=CC2=C1C=CC=C2
Molecular Formula
C10H8N2O2S
Molecular Weight
220.25
Precautions
H302, H315, H319
References & Citations
[1]Mario Mautino, et al. Preparation and disclosure of indoleamine 2,3-dioxygenase (IDO) inhibitors. Patent. WO2009073620.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral mouse Cluh shRNA (UAS) - Lentiviral mouse Cluh shRNA (UAS, RFP) plasmid
N-[ (6S) -6-Carboxy-6- (glycylamino) hexanoyl]-D-alanyl-D-alanine
N-[ (6S) -6-Carboxy-6- (glycylamino) hexanoyl]-D-alanyl-D-alanine
